Clinical trial
A Phase 2 Multicenter, Randomized, Placebo- and Active-Comparator-Controlled, Dose-Ranging Trial to Evaluate CNTO 1959 for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis (X-PLORE)
The purpose of this study is to evaluate the efficacy and safety of CNTO 1959 in the treatment of patients with moderate to severe plaque psoriasis.
| Category | Value |
|---|---|
| Date last updated at source | 2016-03-29 |
| Study type(s) | Interventional |
| Expected enrolment | 293 |
| Study start date | 2011-11-01 |
| Estimated primary completion date | 2013-08-01 |